Y Mizrachi, E Horowitz, J Farhi, A Raziel… - Human …, 2020 - academic.oup.com
BACKGROUND Freeze-all IVF cycles are becoming increasingly prevalent for a variety of clinical indications. However, the actual treatment objectives and preferred treatment …
ESHRE Guideline Group on Ovarian … - Human …, 2020 - academic.oup.com
STUDY QUESTION What is the recommended management of ovarian stimulation, based on the best available evidence in the literature? SUMMARY ANSWER The guideline …
TEGG on Ovarian, E Bosch, S Broer… - Human reproduction …, 2020 - ncbi.nlm.nih.gov
STUDY DESIGN, SIZE, DURATION: The guideline was developed according to the structured methodology for development of ESHRE guidelines. After formulation of key …
A Abbara, PC Eng, M Phylactou… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Kisspeptin is a key regulator of hypothalamic gonadotropin-releasing hormone (GnRH) neurons and is essential for reproductive health. A specific kisspeptin …
KL Hu, Z Chen, X Li, E Cai, H Yang, Y Chen… - Reproductive Biology …, 2022 - Springer
Background Kisspeptin is the leading upstream regulator of pulsatile and surge Gonadotrophin-Releasing Hormone secretion (GnRH) in the hypothalamus, which acts as …
L Engmann, C Benadiva, P Humaidan - Reproductive biomedicine online, 2016 - Elsevier
Gonadotrophin releasing hormone agonist (GnRHa) trigger is effective in the induction of oocyte maturation and prevention of ovarian hyperstimulation syndrome during IVF …
F Martinez, A Racca, I Rodríguez… - Human Reproduction …, 2021 - academic.oup.com
BACKGROUND Since its introduction in the 1980s, oocyte donation (OD) has been largely integrated into ART. Lately, both demand and the indications for OD have increased greatly …
Infertility affects one in six couples, with in vitro fertilization (IVF) offering many the chance of conception. Compared to the solitary oocyte produced during the natural menstrual cycle …
Objective To identify follicle sizes on the day of trigger most likely to yield a mature oocyte following hCG, GnRH agonist (GnRHa), or kisspeptin during IVF treatment. Design …